Instil Bio, Inc. (TIL)

Instil Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.69	8.81	9.2	43.72	37.59	241.71
Short-Term Investments	84.14	104.51	141.16	217.2	416.51	-
Trading Asset Securities	-	-	1.06	2.2	-	-
Cash & Short-Term Investments	91.82	113.32	151.41	263.12	454.1	241.71
Cash Growth	-38.28%	-25.16%	-42.46%	-42.06%	87.87%	2617.41%
Prepaid Expenses	3.32	9.33	7.85	6.26	9.92	4.42
Restricted Cash	0.15	1.83	1.5	-	-	-
Other Current Assets	112.1	-	-	-	-	-
Total Current Assets	207.39	124.47	160.76	269.38	464.02	246.14
Property, Plant & Equipment	0.74	130.34	141.07	209.34	122	55.34
Long-Term Investments	11.66	-	23.16	-	-	-
Goodwill	-	-	-	-	5.72	5.72
Other Intangible Assets	-	-	-	-	10.1	10.1
Long-Term Deferred Charges	-	-	-	-	-	0.5
Other Long-Term Assets	11.2	8.76	0.64	3.41	8.14	1.21
Total Assets	230.99	263.57	325.63	482.13	609.98	319.01
Accounts Payable	0.52	0.66	1.21	2.36	5.57	3.5
Accrued Expenses	12.72	3.48	4.27	9.3	21.45	7.19
Current Portion of Leases	0.46	1.68	1.75	2.38	-	-
Current Income Taxes Payable	-	-	-	-	0.52	0.63
Other Current Liabilities	0.16	2.07	3.33	18.75	13.81	1.97
Total Current Liabilities	13.85	7.9	10.56	32.79	41.36	13.28
Long-Term Debt	84.42	84.19	81.43	72.35	-	-
Long-Term Leases	0.01	1.02	2.88	5.17	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	2.43	2.47
Other Long-Term Liabilities	1.04	1.03	4.94	8.21	11	10.89
Total Liabilities	99.32	94.13	99.8	118.52	54.78	26.65
Additional Paid-In Capital	837.19	824.78	807.16	788.99	757	5.61
Retained Earnings	-704.71	-655.12	-580.98	-424.89	-201.72	-44.92
Comprehensive Income & Other	-0.81	-0.23	-0.35	-0.49	-0.09	-0.28
Total Common Equity	131.67	169.44	225.83	363.61	555.2	-39.6
Shareholders' Equity	131.67	169.44	225.83	363.61	555.2	292.37
Total Liabilities & Equity	230.99	263.57	325.63	482.13	609.98	319.01
Total Debt	84.88	86.89	86.05	79.9	-	-
Net Cash (Debt)	6.94	26.43	65.36	183.22	454.1	241.71
Net Cash Growth	-89.01%	-59.56%	-64.33%	-59.65%	87.87%	2617.41%
Net Cash Per Share	1.06	4.06	10.05	28.29	85.68	302.18
Filing Date Shares Outstanding	6.75	6.53	6.5	6.5	6.46	0.86
Total Common Shares Outstanding	6.75	6.53	6.5	6.5	6.45	0.86
Working Capital	193.53	116.57	150.2	236.59	422.66	232.86
Book Value Per Share	19.50	25.96	34.72	55.91	86.06	-46.15
Tangible Book Value	131.67	169.44	225.83	363.61	539.37	-55.43
Tangible Book Value Per Share	19.50	25.96	34.72	55.91	83.61	-64.60
Land	-	31.24	31.24	31.24	31.24	31.24
Buildings	-	102.43	102.43	32.78	6.03	6.31
Machinery	0.51	0.51	11.14	32.89	17.98	10.46
Construction In Progress	-	-	-	104.12	67.88	6.33
Leasehold Improvements	-	-	1.42	4.34	1.84	1.31

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q